NCT03101462View on ClinicalTrials.gov

Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 24, 2011

Primary Completion Date

May 13, 2011

Study Completion Date

November 9, 2011

Conditions
Influenza
Interventions
BIOLOGICAL

Inactivated Influenza Vaccine

BIOLOGICAL

Live Attenuated Influenza Vaccine

Sponsors

Collaborators (1)

MedImmune LLC
All Listed Sponsors
collaborator

MedImmune LLC

INDUSTRY

lead

St. Louis University

OTHER